Godavari Drugs Peer Comparison

Snapshot Summary

Godavari Drugs Ltd. remains a laggard in growth and profitability compared to its peers in the Pharmaceuticals & Drugs industry. While its valuation metrics suggest it is inexpensive, it shows no earnings or revenue growth, making it a high-risk choice. In the current landscape, companies like Cipla Ltd. and Dr. Reddy's Laboratories Ltd. demonstrate strong financial health and growth potential, standing out as leaders in the sector.

• Godavari Drugs Ltd. shows no growth or profitability metrics, making it a risky investment.
• Cipla Ltd. and Dr. Reddy's Laboratories Ltd. are top performers with strong EPS and ROE.
• Value picks include Cipla and Dr. Reddy’s due to low PEG ratios and solid earnings growth.

• Cipla Ltd.: Strong EPS growth (66.76), low PEG (0.35), and solid ROE (16.63%) with competitive margins.
• Dr. Reddy's Laboratories Ltd.: High EPS growth (68.07), low PEG (0.19), and strong profitability metrics (ROE 21.76%).

Stocks	CMP	Market Cap	P/E	ROCE (%)	Debt/Equity
Godavari Drugs Ltd.	₹82.40	₹62.05Cr	14.17	-	-
SUNPHARMA	₹1,563.35	₹3,75,099.26Cr	87.59	17.60%	0.04
DIVISLAB	₹6,091.05	₹1,61,698.50Cr	73.20	16.46%	-
CIPLA	₹1,587.60	₹1,28,217.27Cr	23.73	22.77%	0.01
TORNTPHARM	₹3,581.55	₹1,21,215.77Cr	61.53	24.28%	0.57
DRREDDY	₹1,280.30	₹1,06,835.27Cr	15.50	26.86%	0.07
MANKIND	₹2,518.95	₹1,03,926.59Cr	55.18	28.38%	0.02

Explore

Watchlists

Command Palette

Godavari Drugs Peer Comparison

Snapshot Summary